SUBSCRIBE
SUBSCRIBE

GSK Bio

NEWS
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Pharm Country
3 Battered and Bruised Life Science Stocks Ready for a Comeback
June 16, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
New York Startup Rgenix Bags $33 Million, Gears Up to Push Drug Once-Shelved by GlaxoSmithKline into Trial
June 15, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Rumors Floating Again that Roche or GlaxoSmithKline Might Acquire Bay Area’s Pacific Biosciences
June 3, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Genetown
Ionis Pharma’s Pain Propels Alnylam to Gain $1.5 Billion in Market Cap
June 1, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Ionis Pharma Plummets After GlaxoSmithKline Opts Not to Initiate Phase III Study for Amyloid Cardiomyopathy Drug
May 26, 2016
 · 
2 min read
Business
Bicycle Therapeutics Sets Up Shop in Massachusetts, Taps a New President and CBO
May 23, 2016
 · 
2 min read
Novartis to Hold On to Its 33% Stake in Roche—For Now
Drug Development
Novartis AG Trial Stopped Early on Positive Data, Gets Ready to Take on Pfizer’s Ibrance
May 19, 2016
 · 
2 min read
Novartis to Hold On to Its 33% Stake in Roche—For Now
Business
Novartis AG’s Pharma Head Exits as Drug Business is Split into Two
May 18, 2016
 · 
2 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
Business
Amid Positive First Quarter Financials, GlaxoSmithKline Boss Expects a Late 2016 Replacement
April 27, 2016
 · 
2 min read
Load More
  • 2026 - Best Places to Work - Badge (1).png
JOBS
IN THE PRESS
Press Releases
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee
May 28, 2025
 · 
9 min read
Press Releases
Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson’s Disease
November 12, 2024
 · 
4 min read
Press Releases
Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk
November 5, 2024
 · 
7 min read
Press Releases
GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons
October 8, 2024
 · 
10 min read
Pharm Country
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
March 7, 2024
 · 
5 min read
Pharm Country
GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies
August 17, 2023
 · 
6 min read
Deals
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
May 16, 2023
 · 
7 min read
Business
AnaptysBio- and GSK-partnered immuno-oncology agent JEMPERLI (dostarlimab-gxly) meets primary endpoint in Phase 3 RUBY trial in primary advanced or recurrent endometrial cancer
December 2, 2022
 · 
5 min read